Advertisement

Topics

Safety Study of the Vascular WrapTM Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access

2014-08-27 03:17:13 | BioPortfolio

Summary

The purpose of this study is to determine whether the long term use of the experimental Vascular WrapTM Paclitaxel-Eluting Mesh is safe in the treatment of subjects needing hemodialysis access (via an ePTFE graft).

Description

The primary objective of this study is to determine long term safety of the Lifespan® ePTFE Vascular Graft and Vascular WrapTM Paclitaxel-Eluting Mesh in comparison to the Lifespan® graft alone.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Conditions

Renal Dialysis

Intervention

Graft, Vascular Wrap

Location

Ladenheim, Inc.
Fresno
California
United States
93710

Status

Terminated

Source

Angiotech Pharmaceuticals

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:17:13-0400

Clinical Trials [2842 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of POSS-PCU Vascular Grafts for Vascular Access

This study evaluates the safety and performance of a new vascular graft made of POSS-PCU as a vascular access conduit for haemodialysis. 30 patients requiring access for dialysis will be e...

Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRD

The purpose of this study is to assess the safety and efficacy of a novel, tissue-engineered vascular prosthesis, the Human Acellular Vascular Graft, HAVG. The HAVG is intended as an alte...

Bio ACL Reconstruction With Amnion Collagen Matrix Wrap and Stem Cells Case Series

The objective of this study is to evaluate the use of wrapping an ACL graft with a collagen matrix tissue wrap and injecting autologous bone marrow aspirate concentrate under the wrapping ...

Comparison of Dialysis Strategies in Critically Ill Patients With Acute Renal Failure

The goal of the present study is the comparison of different dialysis strategies in critically ill patients with acute renal failure on the intensive care unit. Patients are treated with e...

Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

The CSP-1001 study will evaluate the safety and effectiveness of the InnAVasc arteriovenous graft (AVG) when implanted in and used for hemodialysis in participants suffering from end stage...

PubMed Articles [6952 Associated PubMed Articles listed on BioPortfolio]

Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: results from the French transplant database.

Kidney transplantation (KT) is the treatment of choice for end-stage renal disease. Preemptive KT (PKT) should be considered when glomerular filtration rate is

Dialysis vintage and outcomes in renal transplantation.

Pre-emptive kidney transplantation is the recommended strategy for patients with end-stage renal failure in all guidelines [Kidney Disease: Improving Global Outcomes (KDIGO), The Australian and New Ze...

Vascular access placement and mortality in elderly incident hemodialysis patients.

Arteriovenous fistulas (AVFs) are the preferred vascular access type in most hemodialysis patients. However, the optimal vascular access type in octogenarians and older (≥80 years) hemodialysis pa...

Eosinophilic Inflammation in Peritoneal Fibrosis Patients Undergoing Peritoneal Dialysis.

Renal replacement therapy is vital for patients with chronic renal failure. Each type of renal replacement therapy has its own characteristics, and patients select it according on their living environ...

Risk factors for complications and graft failure in kidney transplant patients with sepsis.

Immunosuppressive therapies decreased the incidence of acute kidney rejection after kidney transplantation, but also increased the risk of infections and sepsis. This study aimed to identify the risk ...

Medical and Biotech [MESH] Definitions

Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.

Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION.

Obstruction of flow in biological or prosthetic vascular grafts.

Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution.

The immune responses of a host to a graft. A specific response is GRAFT REJECTION.

More From BioPortfolio on "Safety Study of the Vascular WrapTM Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...

Dialysis
In medicine, dialysis is a process for removing waste and excess water from the blood, and is primarily used to provide an artificial replacement for lost kidney function in people with renal failure. Dialysis may be used for those with an acute disturba...


Searches Linking to this Trial